Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
Journal
The Lancet Oncology
Journal Volume
19
Journal Issue
4
Pages
521-536
Date Issued
2018
Author(s)
Garassino M.C
Cho B.-C
Kim J.-H
Mazières J
Vansteenkiste J
Lena H
Corral Jaime J
Gray J.E
Powderly J
Chouaid C
Bidoli P
Wheatley-Price P
Park K
Soo R.A
Huang Y
Wadsworth C
Dennis P.A
Rizvi N.A
Paz-Ares Rodriguez L
Novello S
Hiret S
Schmid P
Laack E
Califano R
Maemondo M
Kim S.-W
Chaft J
Vicente Baz D
Berghmans T
Kim D.-W
Surmont V
Reck M
Han J.-Y
Holgado Martin E
Belda Iniesta C
Oe Y
Chella A
Chopra A
Robinet G
Soto Parra H
Thomas M
Cheema P
Katakami N
Su W.-C
Kim Y.-C
Wolf J
Lee J.-S
Saka H
Milella M
Ramos Garcia I
Sibille A
Yokoi T
Kang E.J
Atagi S
Spaeth-Schwalbe E
Nishio M
Imamura F
Gabrail N
Veillon R
Derijcke S
Maeda T
Zylla D
Kubiak K
Santoro A
Uy M.N
Lucien Geater S
Italiano A
Kowalski D
Barlesi F
Chen Y.-M
Spigel D
Chewaskulyong B
Garcia Gomez R
Alvarez Alvarez R
Hsia T.-C
Denis F
Sakai H
Vincent M
Goto K
Bosch-Barrera J
Weiss G
Canon J.-L
Scholz C
Aglietta M
Kemmotsu H
Azuma K
Bradbury P
Feld R
Chachoua A
Jassem J
Juergens R
Palmero Sanchez R
Malcolm A
Vrindavanam N
Kubota K
Waller C
Waterhouse D
Coudert B
Mark Z
Satouchi M
Chang G.-C
Herzmann C
Chaudhry A
Giridharan S
Hesketh P
Ikeda N
Boccia R
Iannotti N
Haigentz M
Reynolds J
Querol J
Nakagawa K
Sugawara S
Tan E.H
Hirashima T
Gettinger S
Kato T
Takeda K
Juan Vidal O
Mohn-Staudner A
Panwalkar A
Daniel D
Kobayashi K
Ladrera G.E.I
Schulte C
Sebastian M
Cernovska M
Coupkova H
Havel L
Pauk N
Singh J
Murakami S
Csoszi T
Losonczy G
Price A
Anderson I
Iqbal M
Torri V
Juhasz E
Khanani S
Koubkova L
Levy B
Page R
Bocskei C
Crinò L
Einspahr D
Hagenstad C
Juat N
Overton L
Garrison M
Szalai Z
ATLANTIC Investigators
SDGs
Publisher
Lancet Publishing Group
Type
journal article